Trials Sponsors Conditions Drugs Pricing

Conditions

Cervical Cancer High Grade Cervical Dysplasia

Keywords

Cervical

Outcome Measures

Primary Outcomes (1)

Prevalence
Prevalence of anal dysplasia in women with high grade cervical dysplasia or cervical cancer. Calculated at screening all women with cervical dysplasia or cancer and performing high-resolution anoscopy on those diagnosed with dysplasia.
Screening and up to 24 weeks.

Study Arms (2)

Anal Screening Pap Smear - Negative

OTHER

Anal Pap Smear with no High Resolution Anoscopy

Procedure: Screening Anal Pap Smear - No High Resolution Anoscopy

Anal Pap Smear - Positive Result - High Resolution Anoscopy

OTHER

Patient who have a positive anal pap smear will go on to have a high resolution anoscopy.

Procedure: Screening Anal Pap Smear - With High Resolution Anoscopy

Interventions

Screening Anal Pap Smear - No High Resolution AnoscopyProcedure

Anal Screening Pap Smear - Negative

Screening Anal Pap Smear - With High Resolution AnoscopyProcedure

Anal Pap Smear - Positive Result - High Resolution Anoscopy

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age40 Years+

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Women ≥ 40 years old
Previous or current high grade cervical dysplasia or cervical cancer

You may not qualify if:

Sponsors & Collaborators

Sunnybrook Health Sciences Centre
Otherlead

Study Sites (1)

Odette Cancer Centre

Toronto, Ontario, M4N 3M5, Canada

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

Daniell Vicus, MD
Odette Cancer Centre
PRINCIPAL INVESTIGATOR

Enrollment

355 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: PREVENTION
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Surgical Oncologist in Gynecology Site Group

Study Record Dates

First Submitted

August 26, 2013

First Posted

September 30, 2013

Study Start

October 2014

Date type not reported

This date has not been verified as actual or estimated.

Overlooked Population at Risk for AIN.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Anal Screening Pap Smear - Negative

Anal Pap Smear - Positive Result - High Resolution Anoscopy

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Anal Screening Pap Smear - Negative

Anal Pap Smear - Positive Result - High Resolution Anoscopy

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations